Xiaoping He

ORCID: 0000-0002-0697-6501 · 3 papers in corpus
article 2025
Inhibition of TRPM3 by Primidone Provides a Potential Therapeutic Method for Adenomyosis Management
Drug design, development and therapy ·doi:10.2147/dddt.s494981

PURPOSE: To test the expression profile of transient receptor potential channels (TRPs) in adenomyosis patients and evaluate the effects of primidone on tamoxifen-induced adenomyosis mice. PATIENTS AND METHODS: This study included in vivo …

article 2025
The Scribble-Rac1 signaling axis drives epithelial cell motility and contributes to diffuse adenomyosis pathogenesis
Experimental cell research ·doi:10.1016/j.yexcr.2025.114654

PURPOSE: The study was designed to investigate whether estrogen regulates cell migration through cell polarity signaling and contributes to adenomyosis development. METHODS: In vitro study, Ishikawa cells received different treatments, Wes…

preprint 2023
Inhibition of TRPM3 by primidone provides a potential therapeutic method for adenomyosis management
·doi:10.21203/rs.3.rs-3217639/v1

Abstract Purpose To test the expression profile of transient receptor potential channels (TRPs) in adenomyosis patients and evaluate the effects of primidone on tamoxifen-induced adenomyosis mice. Methods Eutopic endometrium from adenomyosi…